Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2022

Biopharmaceutical Research Co

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CASTROVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Charles B. Schumacher · Castroville, CADirectorGeorge B. Hodgin · Castroville, CAExec · DirectorRobert Hillman · Del Mar, CAExec · DirectorStephen Kurz · New York, NYDirectorDaniel M. Green · Greenwich, CTDirectorScott W. Corkery · Greenwich, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗